التفاصيل البيبلوغرافية
| العنوان: |
Effect of Early Metoprolol Before PCI in St-Segment Elevation Myocardial Infarction on Infarct Size and Left Ventricular Ejection Fraction. A Systematic Review and Meta-Analysis. |
| المؤلفون: |
Motawea, Karam R., Gaber, Hamed, Singh, Ravi B, Swed, Sarya, Elshenawy, Salem, Talat, Nesreen Elsayed, Elgabrty, Nawal, Shoib, Sheikh, Wahsh, Engy A., Gebril, Sara, Kishk, Mohamed, Elkoumi, Omar A., Attia, Mazen, Khalifa, Ahmed, Habib, Omar Khaled, Foad, Ahmed, Tanas, Yousef, Dean, Yomna E., Hasan, Walaa, Aiash, Hani |
| المصدر: |
American Heart Journal; Dec2022, Vol. 254, p250-251, 2p |
| مستخلص: |
ST-segment elevation myocardial infarction (STEMI) is the most life threatening condition for people with coronary artery disease. Metoprolol has been reported to reduce the size of myocardial infarctions (MIS) while maintaining LV function. The goal of this meta-analysis is to evaluate the impact of early intravenous metoprolol in STEMI before PCI on infarct size, as measured by CMR, and left ventricular ejection fraction. From inception to 18 January 2022, we searched the following databases: PubMed, Scopus, Cochrane library, and Web of Science. We included only randomized control trials that reported the use of early intravenous metoprolol in STEMI before PCI on infarct size, as measured by CMR, and left ventricular ejection fraction. RevMan software 5.4 was used for performing the analysis. Following a literature search, 340 publications were found. Finally, 18 studies were included for the systematic review and 8 clinical trials were included in the meta-analysis after full text screening. At one week, the pooled effect revealed a statistically significant association between Metoprolol and increased LVEF (%) compared to controls (MD= 2.98, [95 % CI= 1.26 to 4.69], P = 0.0007), as well as decreased infarcted myocardium (%) compared to controls (MD= -3.21, [95 % CI= -5.24 to -1.18], P = 0.002). At 6 months, the pooled effect revealed a statistically significant association between Metoprolol and increased LVEF (%) compared to controls (MD= 3.57, [95 % CI= 2.22 to 4.92], P < 0.00001), as well as decreased infarcted myocardium(g) compared to controls (MD= -3.84, [95 % CI= -5.75 to -1.93], P < 0.0001). Early intravenous Metoprolol could reduce the infarct's size and improve the LVEF% in STEMI patients, before PCI, at one-week and 6-month. More multicenter randomized clinical trials are needed to back up our findings. [ABSTRACT FROM AUTHOR] |
|
Copyright of American Heart Journal is the property of Elsevier B.V. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Supplemental Index |
